Vitamin D3

What is vitamin D3?

Vitamin D3, or cholecalciferol, is made in skin exposed to UVB sunlight. It helps calcium absorption and bone maintenance and acts through receptors in several tissues. Food sources include fatty fish and fortified products.

The forms that matter

Where does vitamin D come from?

Sunlight is the primary source; UVB converts a cholesterol precursor in skin to D3. Dietary sources are thin: fatty fish, egg yolks, UV-exposed mushrooms (D2), and fortified milk/cereals. That’s why insufficiency is endemic at northern latitudes, in winter, in people who work indoors, and in adults over 60 whose skin makes markedly less, the exact demographic most supplements target.

How does vitamin D3 work in the body?

D3 is converted in the liver to 25-hydroxyvitamin D (25(OH)D), the storage form blood tests measure, then in the kidneys to calcitriol, the active hormone that drives intestinal calcium absorption and modulates immune-cell and muscle function. Receptors sit in tissue throughout the body, which is why deficiency correlates with such a broad list of problems, and why researchers keep testing whether supplementation prevents them.

What is vitamin D3 claimed to do?

Beyond bone health: testosterone support, immunity/respiratory-infection resistance, mood, muscle strength and fall prevention, cancer and cardiovascular protection, and urinary/prostate symptom relief in men.

What does the research show?

The VITAL reality check

Manson et al. (2019, NEJM): 25,871 adults, 2,000 IU/day, median 5.3 years, no reduction in invasive cancer incidence or major cardiovascular events. It’s the largest vitamin-D trial ever run and it reset the field: vitamin D is essential to replete, not a drug that prevents disease in people who already have enough. (Secondary analyses did show reduced autoimmune-disease incidence: interesting, hypothesis-generating, not definitive.)

Respiratory infections — the finding that survived

Martineau et al. (2017, BMJ): individual-participant meta-analysis of 25 trials (~11,000 people) found daily or weekly D3 supplementation reduced acute respiratory infections, with the strongest protection in people whose baseline 25(OH)D was under 10 ng/mL. Crucially, large monthly boluses didn’t work; consistent daily dosing did.

Testosterone — the effects of deficiency

Pilz et al. (2011): overweight men with low vitamin D given ~3,300 IU/day for a year showed a modest testosterone rise versus placebo. It’s the study behind every “D3 for T” claim, and it hasn’t generalized to men with adequate levels. The version: fixing deficiency helps hormones; surplus doesn’t.

Form — D3 vs D2

Tripkovic et al. (2012, AJCN meta): D3 raises and sustains 25(OH)D significantly better than D2, roughly a third to nearly double the response depending on regimen. Any label still using D2 is cutting a corner.

What doesn’t vitamin D3 do?

It doesn’t boost testosterone in replete men, doesn’t prevent cancer or heart disease (VITAL), and megadose “immune-boosting” doesn’t outperform consistent moderate dosing, while raising the only real risk this vitamin has: hypercalcemia (too much calcium in the blood).

What dose was studied?

Supplement trials cluster at 1,000–4,000 IU/day; the RDA is 600–800 IU. The correct frame: dose targets a blood level (25(OH)D 20–50 ng/mL), and 1,000–2,000 IU/day is the research-grade default for adults with low sun exposure.

How much is too much?

UL: 4,000 IU/day for adults. Toxicity is hypercalcemia (nausea, kidney stones, confusion): real but almost always chronic 10,000+ IU/day territory or unmonitored prescription doses.

Deficiency — who’s at risk?

Older adults, people with darker skin, the obese (D sequesters in fat), indoor workers, and fat-malabsorption conditions (celiac, bariatric). Deficiency = 25(OH)D <12 ng/mL; insufficiency <20 ng/mL. A blood test is the only reliable check.

Side effects

Essentially none at ≤4,000 IU/day; the toxicity story is entirely a chronic-megadose story.

Drug interactions

• Thiazide diuretics: additive hypercalcemia risk
• Digoxin: hypercalcemia potentiates arrhythmia
• Orlistat, bile-acid resins: reduce D absorption
• Long-term corticosteroids: impair D metabolism (a reason doctors prescribe D alongside)

Who should not take vitamin D3?

People with hypercalcemia, granulomatous diseases (sarcoidosis), or certain kidney conditions, unless a physician is monitoring levels.

What the authorities say

NIH ODS maintains the full professional fact sheet (intakes, UL, deficiency thresholds). The Endocrine Society’s 2024 guideline notably advised against routine 25(OH)D screening and against routine supplementation beyond the RDA for most healthy adults, a deliberately conservative stance that sparked debate precisely because insufficiency is so common. Read together: the establishment says “correct deficiency, don’t chase surplus,” which is exactly what the trials show.

What to know about vitamin D3

Vitamin D benefits are strongest when correcting low levels. More does not necessarily help once intake is adequate. Count all sources and stay within the adult 4,000 IU upper limit unless a clinician directs otherwise; commonly discussed supplemental amounts are 1,000–2,000 IU.